# Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells

> **NCT04418934** · PHASE2 · WITHDRAWN · sponsor: **Hemanext**

## Conditions studied

- Whole Blood Donations and Leukoreduction

## Interventions

- **DEVICE:** Hemanext One

## Key facts

- **NCT ID:** NCT04418934
- **Lead sponsor:** Hemanext
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-07-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Grant application for study was rejected
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04418934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04418934, "Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04418934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*